In vivo and in vitro efficacy of octreotide for treatment of enteric cryptosporidiosis

Digestive Diseases and Sciences

Volumn 43, Issue 2, 1998, Pages 436-441

  Guarino, Alfredo ^a   Canani, Roberto Berni ^a   Spagnuolo, Maria Immacolata ^a   Bisceglia, Massimo ^a   Boccia, Maria Cristina ^a   Rubino, Armido ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cryptosporidium; Diarrhea; Enterotoxin; HIV infection; Octreotide; Somatostatin

Indexed keywords

OCTREOTIDE; SPIRAMYCIN;

ARTICLE; CASE REPORT; CRYPTOSPORIDIOSIS; DIARRHEA; FECES ANALYSIS; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SODIUM EXCRETION; SUBCUTANEOUS DRUG ADMINISTRATION;

CACO-2 CELLS; CRYPTOSPORIDIOSIS; DIARRHEA, INFANTILE; FATAL OUTCOME; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFANT; MALE; OCTREOTIDE;

EID: 0031939730     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018839329759     Document Type: Article

References (25)

1. Adal KA, Sterling CR, Guerrant RL: Cryptosporidium and related species. In Infections of the Gastrointestinal Tract. MJ Blaser, PD Smith, JI Ravdin, RL Guerrant (eds). New York, Raven Press, 1945, pp 1107-1128
2. Guarino A, Spagnuolo MI, Russo S, Albano F, Guandalini S, Capano G, Cucchiara S, Vairano P, Liguori R, Casola A, Rubino A: Etiology and risk factors of severe and protracted diarrhea. J Pediatr Gastroenterol Nutr 20:173-178, 1995
3. Guarino A, Berni Canani R, Pozio E, Terracciano L, Albano F, Mazzeo M: Enterotoxic effect of stool supernatant of Cryptosporidium infected calves on human jejunum. Gastroenterology 106:28-34, 1994
4. Guarino A, Berni Canani R, Casola A, Pozio E, Russo R, Bruzzese E, Fontana M, Rubino A: Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis 171:476-983, 1995
5. Field M, Rao MC, Chang EB: Intestinal electrolyte transport and diarrheal disease (first of two parts). N Engl J Med 21:800-806, 1984
6. Montaner JSG, Harris AG, Octreotide International Multicentre AIDS/Diarrhea Study Group: Octreotide therapy in AIDS-related, refractory diarrhea: Results of a multicentre Canadian-European study. AIDS 9:209-210, 1995
7. Harris AG, D'Orisio TM, Woltering EA, Anthony LB, Burton FR, Geller RB, Grendell JH, Levin B, Redfern JS: Consensus statement: Octreotide dose titration in secretory diarrhea. Diarrhea management consensus development panel. Dig Dis Sci 40:1464-1473, 1995
8. Lamberts SWJ, Van der Lely AJ, De Herder WW, Hofland LJ: Octreotide. N Engl J Med 334:246-254, 1996
9. Gomez-Morales MA, Ausiello CM, Guarino A, Urbani F, Pignata C, Spagnuolo MI, Pozio E: Severe, protracted intestinal cryptosporidiosis associated with interferon-γ deficiency: Pediatric case report. Clin Infect Dis J 22:848-850, 1996
10. Cook DJ, Kelton JG, Stanisz AM, Collins SM: Somatostatin treatment for eryptosporidial diarrhea in a patient with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:708-709, 1988
11. Edwards CA, Cann PA, Read NW, Holdsworth CD: The effect of somatostatin analogue SMS 201-885 on fluid and electrolyte transport in a patient with secretory diarrhea. Scand J Gastroenterol 21(suppl 119):259-261, 1986
12. Ohlbaum Ph, Galperine RI, Demarquez JL, Vergnes P, Martin CL: Use of a long acting somatostatin analogue (SMS 201-995) in controlling a significant ileal output in a 5-year-old child. J Pediatr Gastroenterol Nutr 6:466-470, 1987
13. Johansson C, Efendic S, Wisen O, Uvnas-Wallenstein K, Luft R: Effects of short time somatostatin infusion on the gastric and intestinal propulsion in humans. Scand J Gastroenterol 13:481-483, 1978
14. Carter RF, Bitar KN, Zfass AM, Markhlouf GM: Inhibition of VIP-stimulated intestinal secretion and cAMP production by somatostatin in the rat. Gastroenterology 74:726-730, 1978
15. Ruskone A, Rene E, Chayvialle JA: Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patients with pancreatic cholera. Dig Dis Sci 27:459-466, 1982
16. Guentar JK, Brown R, Raskin P: Effect of intravenous somatostatin on jejunal absorption of glucose, amino acid, water and electrolyte. Gastroenterology 78:26-31, 1980
17. Dharmasathaphorn K, Sherwin RS, Dobbins JW: Somatostatin inhibits fluid secretion in the rat jejunum. Gastroenterology 78:1554-1558, 1980
18. Fassler JE, D'Orisio TM, Mekhjian HS, Gaginella TS: Octreotide inhibits increases in short circuit current induced in rat colon by VIP, substance P. serotonin and aminophylline. Regul Pept 29:189-197, 1990
19. Diener M, Gartman V: Effect of somatostatin on cell volume, Cl currents, and transepithclial Cl transport in rat distal colon. Am J Physiol 266:G1043-G1052, 1994
20. Guandalini S, Kachur JF, Smith PL, Miller RJ, Field M: In vitro effect of somatostatin on ion transport in rabbit intestine. Am J Physiol 238:G67-G74, 1980
21. Bisset WM, Jenkins H, Booth I, Smith V, Milla PJ: The effect of somatostatin on small intestinal transport in intractable diarrhoea in infancy. J Pediatr Gastroenterol Nutr 17:169-175, 1993
22. Couper R, Frischman W: Somatostatin and small intestinal transport. J Pediatr Gastroenterol Nutr 19:137-138, 1994
23. Cello JP, Grendell JH, Basuk P, Simon D, Weiss L, Wittner M, Rood RP, Wilcox CM, Forsmark CE, Read AE: Effect of octrcotidc on refractory AIDS-associated diarrhea: A prospective multicenter clinical trial. Ann Intern Med 115:705-710, 1991
24. Harris AG: Octreotide in the treatment of disorders of the gastrointestinal tract. Drug Invest 4:1-54, 1992
25. Romeu J, Miro JM, Sirera G, Mallolas J, Arnal J, Valls ME, Tortosa F, Clotet B, Foz M: Efficacy of octreotide in the management of chronic diarrhoea in AIDS. AIDS 5:1495-1499, 1991